Cargando…

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies

The lectin, galectin-3 (Gal3), has been implicated in a variety of inflammatory and oncogenic processes, including tumor growth, invasion, and metastasis. The interactions of Gal3 and MUC16 represent a potential targetable pathway for the treatment of MUC16-expressing malignancies. We found that the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stasenko, Marina, Smith, Evan, Yeku, Oladapo, Park, Kay J., Laster, Ian, Lee, Kwangkook, Walderich, Sven, Spriggs, Elizabeth, Rueda, Bo, Weigelt, Britta, Zamarin, Dmitriy, Rao, Thapi Dharma, Spriggs, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881041/ https://www.ncbi.nlm.nih.gov/pubmed/33580170 http://dx.doi.org/10.1038/s41598-021-82686-3

Ejemplares similares

Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition
por: Yeku, Oladapo O., et al.
Publicado: (2021)

Galectins and Ovarian Cancer
por: Shimada, Chisa, et al.
Publicado: (2020)

Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion
por: Rao, Thapi D., et al.
Publicado: (2015)

A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
por: Yeku, Oladapo, et al.
Publicado: (2020)

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
por: Yeku, Oladapo O., et al.
Publicado: (2017)

Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors
por: Elkin, Rena, et al.
Publicado: (2021)

Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer
por: Lam, Clarissa, et al.
Publicado: (2023)

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer
por: Koneru, Mythili, et al.
Publicado: (2015)

High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma
por: Morales-Vásquez, Flavia, et al.
Publicado: (2016)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer
por: Bachmann, Robert, et al.
Publicado: (2021)

Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer
por: Bachmann, Robert, et al.
Publicado: (2021)

CA125/MUC16 Is Dispensable for Mouse Development and Reproduction
por: Cheon, Dong-Joo, et al.
Publicado: (2009)

Aberrant MUC1-TRIM46-KRTCAP2 Chimeric RNAs in High-Grade Serous Ovarian Carcinoma
por: Kannan, Kalpana, et al.
Publicado: (2015)

Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers
por: Labrie, Marilyne, et al.
Publicado: (2017)

Radium-223 and concomitant therapies: prospects and prudence
por: Yeku, Oladapo, et al.
Publicado: (2016)

Galectin-3 and Epithelial MUC1 Mucin—Interactions Supporting Cancer Development
por: Radziejewska, Iwona
Publicado: (2023)

GSN - The Goal Structuring Notation: A Structured Approach to Presenting Arguments
por: Spriggs, John
Publicado: (2012)

Children and bioethics: clarifying consent and assent in medical and research settings
por: Spriggs, Merle
Publicado: (2023)

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
por: Williams, Kristina A., et al.
Publicado: (2014)

Hector Gavin, MD, FRCSE (1815-1855)--his life, his work for the sanitary movement, and his accidental death in the Crimea.
por: Spriggs, E A
Publicado: (1984)

Aspiration Biopsy Cytology—Part I
por: Spriggs, A. I.
Publicado: (1974)

Colour Atlas of Gynaecological Cytology
por: Spriggs, A. I.
Publicado: (1977)

John Hutchinson, the inventor of the spirometer--hisnorthcountrybackground, life in London, and scientific achievements.
por: Spriggs, E A
Publicado: (1977)

The illnesses and death of Robert Walpole.
por: Spriggs, E A
Publicado: (1982)

The Physiology of the Appetite
por: Spriggs, E. I.
Publicado: (1910)

mSphere of Influence: Viruses—Pathogens or Expert Cell Biologists?
por: Spriggs, Chelsey C.
Publicado: (2021)

Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma
por: Pranjol, Md Zahidul I., et al.
Publicado: (2019)

Conflicting Views on the Molecular Structure of the Cancer Antigen CA125/MUC16
por: Bouanene, Houda, et al.
Publicado: (2010)

PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature
por: Ramos, Amanda, et al.
Publicado: (2020)

Highly glycosylated MUC1 mediates high affinity L-selectin binding at the human endometrial surface
por: Francis, Lewis W., et al.
Publicado: (2021)

Cytopathologie des Cancers Bronchopulmonaires
por: Spriggs, D. A. I.
Publicado: (1976)

State of the art in AIT: The patients’ perspective
por: Jossé, Sabine, et al.
Publicado: (2022)

HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy
por: Xiang, Xinran, et al.
Publicado: (2011)

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
por: Felder, Mildred, et al.
Publicado: (2014)

Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells
por: Huang, Yao, et al.
Publicado: (2021)

Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies
por: Wang, Chien-Wei, et al.
Publicado: (2023)

Commentary: The neural basis of human female mate copying: An empathy-based social learning process
por: Luoto, Severi, et al.
Publicado: (2018)

Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer
por: Jin, Xiayu, et al.
Publicado: (2022)

Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma
por: Kinzler, Maximilian N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_unfe38gdd2ev3vnatdghf1pun4